| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.500 | None | 0.909 | 12 | 5 | 1992 | 2017 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.400 | None | 1.000 | 12 | 0 | 1995 | 2019 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.330 | None | 1.000 | 3 | 1 | 1995 | 2010 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.330 | None | 1.000 | 3 | 0 | 2002 | 2017 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.330 | None | 1.000 | 2 | 0 | 2002 | 2014 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2000 | 2010 | ||||||||
|
transforming growth factor alpha | 0.432 | 0.885 | 0.72 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 1991 | 1999 | ||||||||
|
cyclin dependent kinase inhibitor 1A | 0.403 | 0.769 | 1.9E-03 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2002 | 2017 | ||||||||
|
ornithine decarboxylase 1 | 0.510 | 0.731 | 0.17 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 1995 | 2007 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2001 | 2011 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.130 | None | 0.667 | 3 | 0 | 2000 | 2012 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.130 | None | 1.000 | 3 | 2 | 2000 | 2018 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.120 | None | 1.000 | 2 | 1 | 2010 | 2018 | ||||||||
|
XPA, DNA damage recognition and repair factor | 0.520 | 0.846 | 7.9E-05 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.100 | None | 0.968 | 60 | 4 | 1992 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.100 | None | 1.000 | 32 | 1 | 1999 | 2019 | ||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
disease | 0.100 | None | 1.000 | 22 | 0 | 2004 | 2019 | |||||||||
|
plasminogen activator, tissue type | 0.445 | 0.885 | 5.7E-05 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 1988 | 2018 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1998 | 2011 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.050 | None | 1.000 | 5 | 2 | 2014 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.040 | None | 1.000 | 4 | 3 | 2011 | 2019 | ||||||||
|
DEK proto-oncogene | 0.542 | 0.769 | 0.13 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2009 | 2015 | ||||||||
|
ubiquitin conjugating enzyme E2 B | 0.644 | 0.615 | 0.20 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1987 | 2005 | ||||||||
|
potassium voltage-gated channel interacting protein 3 | 0.626 | 0.654 | 3.8E-02 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2018 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1997 | 2007 |